Meet our team.
Dr. Kazunari Yoshida, MD PhD
Psychiatrist, Postdoctoral Fellow
Azrieli Adult Neurodevelopmental Centre | CAMH
Department of Neuropsychiatry | Keio University School of Medicine, Tokyo, Japan
Dr. Kazunari Yoshida received his MD from Tokushima University, Japan, in 2007, and his PhD from the Keio University School of Medicine, Japan, in 2017, respectively. He has been performing a series of clinical trials, focusing on optimal psychotropic treatment for psychiatric disorders. Since joining Pharmacogenetics Research Clinic at CAMH as a postdoctoral research fellow, he has specialized in pharmacogenetics and clinical psychopharmacology in psychiatric conditions including schizophrenia, and adults with autism spectrum disorder and intellectual disability. Dr. Yoshida aims to identify genetic factors that predict response to psychotropic medications, including antipsychotic and antidepressant medications, which can ultimately optimize pharmacological treatment in these populations.
Follow Dr. Yoshida on ResearchGate, LinkedIn, and Twitter!
Dr. Yoshida’s Projects
Antipsychotic-Induced Weight Gain
Pharmacogenetics in Adults with ASD/ID
Selected Publications
Psychiatric manifestations of Kleefstra syndrome: a case report
Yoshida K, Müller DJ & Desarkar P. Frontiers in psychiatry. 2023; 14, 1174195.
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study
Yoshida K, Marshe VS, Elsheikh SSM, Maciukiewicz M, Tiwari AK, Brandl EJ, Lieberman JA, Meltzer HY, Kennedy JL & Müller DJ. The pharmacogenomics journal. 2023; 10.1038/s41397-023-00305-y. Advance online publication.
Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review
Yoshida K, Koyama E, Zai CC, Beitchman JH, Kennedy JL, Lunsky Y, Desarkar P, Müller DJ. Can J Psychiatry. 2021; 66(12):1019-1041.